![]() This cookie is used for load balancing purposes. SiteLock sets this cookie to provide cloud-based website security services. The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. The TiPMix cookie is set by Azure to determine which web server the users must be directed to. The cookie is a session cookies and is deleted when all the browser windows are closed. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. This cookie is native to PHP applications. The JSESSIONID cookie is used by New Relic to store a session identifier so that New Relic can monitor session counts for an application.Ī load balancing cookie set to ensure requests by a client are sent to the same origin server. Used to help protect the website against Cross-Site Request Forgery attacks This cookie is associated with Django web development platform for python. The cookie is used to store the user consent for the cookies in the category "Performance". This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. The cookies is used to store the user consent for the cookies in the category "Necessary". The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". The cookie is used to store the user consent for the cookies in the category "Analytics". Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category. This cookie is used to manage the interaction with the online bots. ![]() This cookie is set by the provider Akamai Bot Manager. This cookie is managed by Amazon Web Services and is used for load balancing. Issued by Microsoft's ASP.NET Application, this cookie stores session data during a user's website visit. ![]() This cookie is used to detect and defend when a client attempt to replay a cookie.This cookie manages the interaction with online bots and takes the appropriate actions. These cookies ensure basic functionalities and security features of the website, anonymously. Her ongoing interventions aim to: 1) repurpose nicotinic acetylcholine receptor partial agonists for heavy-drinking smokers with HIV, 2) test high-dose n-3 long chain polyunsaturated fatty acid supplementation for smoking cessation in pregnancy, and 3) bring precision to addiction treatment by tailoring pharmacotherapy to genetic variability in hepatic nicotine metabolism.Necessary cookies are absolutely essential for the website to function properly. Tindle conceptualizes, develops, and tests efficacy of novel clinical interventions while simultaneously probing their mechanisms. When used during temptations, nicotine gum reduced odds of lapsing by 55%, indicating a role for short-acting nicotine in non-daily smokers.īoard certified in addition medicine, Dr. In this placebo-controlled randomized trial, nicotine gum use was low and did not increase rates of continuous abstinence at 6 months. Her pioneering trial of nicotine gum for cessation in non-daily smokers was the first to report on efficacy of medicinal nicotine in this population, and to establish that nicotine gum used during a temptation to smoke can avert a lapse to smoking. Published in JAMA, the former study earned the American Heart Association’s Paul Dudley White award. Tindle’s seminal work leveraging the Framingham Heart Study established that former smokers remain at increased risk for CVD and lung cancer for up to 25 years after quitting smoking, findings which exposed the underestimation of smoking-related disease risk for millions of former smokers. She has had sustained R01 funding from multiple NIH institutes, served on NIH study section panels, led a National Cancer Institute Tobacco Control Monograph chapter, and contributes to US Surgeon General’s Reports on Tobacco Control.ĭr. Her research program integrates observational studies with clinical trials to improve health among nicotine users. Hilary Tindle is the inaugural William Anderson Spickard, Jr., Endowed Chair in Addiction Medicine at Vanderbilt University Medical Center and a leading international physician investigator focused on the impact of nicotine addiction on human health. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |